300. IgG4-related disease Clinical trials / Disease details

Clinical trials : 36 /  Drugs : 49 - (DrugBank : 22) / Drug target genes : 16 - Drug target pathways : 98

  
3 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04520451
(ClinicalTrials.gov)		August 22, 202011/8/2020Open Label Two-Arm Study to Evaluate Rilzabrutinib (PRN1008) in IgG4-Related Disease PatientsAn Open Label, Two-Arm Study to Evaluate the Effect of Rilzabrutinib (PRN1008) on Safety and Disease Activity in Patients With IgG4-Related DiseaseIgG4-Related DiseaseDrug: rilzabrutinib;Drug: GlucocorticoidsPrincipia Biopharma, a Sanofi CompanyMassachusetts General HospitalRecruiting18 YearsN/AAll25Phase 2United States;Canada
2ChiCTR2000028918
2020-01-012020-01-07A randomized, double-blind controlled study of glucocorticoids combination with thalidomide in the treatment of IgG4-related diseasesEfficacy and safety of thalidomide in IgG4-related diseases IgG4 related diseasecontrol group:prednison combined with placebo;experimental group:prednison combined with thalidomide;Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNULLRecruiting1880Bothcontrol group:51;experimental group:51;Phase 4China
3NCT01758393
(ClinicalTrials.gov)		December 201224/12/2012Glucocorticoids in Patients With IgG4-RDA Randomized Trial of Glucocorticoids in Patients With IgG4-Related DiseaseIgG4-related DiseaseDrug: PrednisonePeking Union Medical College HospitalNULLRecruiting18 Years70 YearsBoth40Phase 2/Phase 3China